Study of Pregabalin Therapy for Pain Relief in Subjects With Post-Herpetic Neuralgia

Viatris

Status and phase: Completed; Phase 4

Conditions: Post-Herpetic Neuralgia

Treatments: Drug: pregabalin

Study type: Interventional

Funder types: Industry

Identifiers

NCT00159666

A0081004

Details and patient eligibility

About

The purpose of this study is to measure how rapidly pregabalin treatment can relieve pain in patients with post-herpetic neuralgia

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Diagnosis of PHN with pain present for at least three months after the healing of a Herpes Zoster skin lesion.
• Subjects must have completed the Daily Pain Rating Scale in the electronic diary at least 4 times during screening and have an average daily pain rating score of greater than or equl to 4 during the 7 +/- 3 days prior to randomization (Visit 2).

Exclusion criteria

• History of neurolytic or neurosurgical therapy for PHN.
• Presence of any severe pain associated with conditions other than PHN that may confound the assessment or self-evaluation of the pain due to PHN.

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind